AshiBio
Cambridge, United States · Founded 2022 · $40.0M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 11–50
- Founded
- 2022
- Business Model
- B2B
- Website
- ashibio.com
- Total Funding
- $40.0M
- Last Round
- SeedJun 2024
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Clinical-stage biotech developing novel therapeutics for bone and connective tissue disorders.
Summary
AshiBio is a Biotech company based in Cambridge, United States, founded in 2022. It has raised $40.0M in total across 2 rounds, most recently a Seed round in Jun 2024. Investors include MPM BioImpact, Agent Capital and YK Bioventures.
Tech & App Stack
1 technology or app tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jun 2024
Sign up to see all 2 events
Funding: Seed through Series A. Amounts, valuations, and investors where available.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/ashibio"><img src="https://indexed.vc/api/badge/company/ashibio" alt="AshiBio on Indexed.vc" width="260" height="76" /></a>